Immune Cytopenia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2026-04-02
Clinical Trial Update: Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic Hematopoietic Cell Transplantation [Phase 2]
Open-label Phase II trial evaluating isatuximab for patients with refractory immune cytopenias after allogeneic hematopoietic cell transplan…